サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：がんの温熱療法（ハイパーサーミア）市場の世界市場- 業界分析、規模、シェア、成長、動向、予測（2031年）- 機器タイプ別、エンドユーザー別、用途別、地域別
市場調査レポート
商品コード
1389766

がんの温熱療法（ハイパーサーミア）市場の世界市場- 業界分析、規模、シェア、成長、動向、予測（2031年）- 機器タイプ別、エンドユーザー別、用途別、地域別

Hyperthermia Treatment for Cancer Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:

出版日
ページ情報
英文 121 Pages
納期
2～5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
がんの温熱療法（ハイパーサーミア）市場の世界市場- 業界分析、規模、シェア、成長、動向、予測（2031年）- 機器タイプ別、エンドユーザー別、用途別、地域別
出版日: 2023年11月22日
発行: Fairfield Market Research
ページ情報: 英文 121 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のがんとの闘いは、温熱療法（ハイパーサーミア）の隆盛によって大きく飛躍しました。

がんは世界的に増加傾向にあり、世界保健機関（WHO）は2030年までに約1,310万人ががんに関連して死亡すると予測されています。また、WHOのデータによると、2008年から2030年にかけて世界のがん有病率は75％増加します。このようながん罹患率の上昇が、がん治療を求める患者数の急増を促し、温熱療法の需要を押し上げています。

治療効果に対する認識様々な悪性疾患に対する温熱療法の治療効果に対する認識の高まりが、世界の温熱療法機器市場の収益拡大に寄与しています。この分野の専門家は、化学療法と併用することで腫瘍細胞を破壊し薬物吸収を高める温熱療法の可能性について患者を教育しています。温熱療法と放射線療法を組み合わせた臨床試験では、単独の放射線療法と比較して優れた有効性が示されており、温熱療法の利点がさらに強調されています。

コストの課題温熱療法はその有効性にもかかわらず、他のがん治療法と比較して高額であることが市場成長の大きな障害となっています。米国では、各がん種に対する温熱療法の平均料金は約50,000米ドルです。温熱療法は放射線療法や化学療法を補完することが多いため、多くの患者にとって全体的な費用は法外なものとなります。

新興経済諸国における未開発の機会中国やインドのような人口が多く、がんの罹患率が高い諸国には、温熱療法の未開発の機会があります。これらの国々では現在、がん治療のための施設や経験豊富な施術者の数は限られているが、がんの罹患率の増加がヘルスケアインフラの拡大を後押ししています。このような市場開発により、温熱療法機器メーカーは新興経済諸国のニーズに合わせた費用対効果が高く利用しやすい製品を投入する有望な市場を形成しています。

当レポートでは、世界のがんの温熱療法（ハイパーサーミア）市場について調査し、市場の概要とともに、機器タイプ別、エンドユーザー別、用途別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • ウクライナとロシアの紛争の影響
  • 経済概要
  • PESTLE分析

第3章 生産高と貿易統計、2018年～2023年

第4章 価格分析、2018年～2023年

第5章 世界のがんの温熱療法（ハイパーサーミア）市場の見通し、2018年～2031年

  • 世界のがんの温熱療法（ハイパーサーミア）市場の見通し、機器タイプ別、金額（100万米ドル）、数量（100万台）、2018年～2031年
  • 世界のがんの温熱療法（ハイパーサーミア）市場の見通し、用途別、金額（100万米ドル）、数量（100万台）、2018年～2031年
  • 世界のがんの温熱療法（ハイパーサーミア）市場の見通し、エンドユーザー別、金額（100万米ドル）、数量（100万台）、2018年～2031年
  • 世界のがんの温熱療法（ハイパーサーミア）市場の見通し、地域別、金額（100万米ドル）、数量（100万台）、2018年～2031年

第6章 北米のがんの温熱療法（ハイパーサーミア）市場の見通し、2018年～2031年

第7章 欧州のがんの温熱療法（ハイパーサーミア）市場の見通し、2018年～2031年

第8章 アジア太平洋のがんの温熱療法（ハイパーサーミア）市場の見通し、2018年～2031年

第9章 ラテンアメリカのがんの温熱療法（ハイパーサーミア）市場の見通し、2018年～2031年

第10章 中東・アフリカのがんの温熱療法（ハイパーサーミア）市場の見通し、2018年～2031年

第11章 競合情勢

  • 動脈タイプと適応症のヒートマップ
  • メーカーと適応症のヒートマップ
  • 企業の市場シェア分析、2023年
  • 競争力ダッシュボード
  • 企業プロファイル
    • Celsius42 GmbH
    • Pyrexar Medical Inc.
    • Oncothermia
    • Hydrosun GmbH
    • Yamamoto Vinita Co., Ltd
    • Andromedic Srl
    • Haifu Medical Technology Co. Ltd

第12章 付録

目次

The global fight against cancer has taken a significant leap forward with the prominence of hyperthermia treatment. A recent report sheds light on the state of the global hyperthermia treatment for cancer market, highlighting key product types, market drivers, challenges, and emerging opportunities in this critical healthcare sector.

Microwave Hyperthermia Device Dominates In terms of revenue, the microwave hyperthermia device segment has emerged as the dominant product type in the global hyperthermia treatment for cancer market. This segment is poised to further gain traction during the forecast period, thanks to its unique ability to efficiently transmit energy from antennas to cancer cells without becoming hindered by fat layers.

Rising Cancer Incidence Fuels Growth Cancer is on the rise worldwide, with the World Health Organization projecting approximately 13.1 million cancer-related deaths by 2030. The data from WHO also indicates a 75% increase in global cancer prevalence from 2008 to 2030. This escalating cancer incidence is driving an upsurge in the number of patients seeking cancer therapies, subsequently boosting the demand for hyperthermia treatment.

Awareness of Therapeutic Benefits Growing awareness of the therapeutic benefits of hyperthermia for various malignant diseases is contributing to the revenue growth of the global hyperthermia devices market. Experts in the field are educating patients about hyperthermia's potential to destroy tumor cells and enhance drug absorption when used in conjunction with chemotherapy. Clinical trials combining hyperthermia with radiation therapy have shown superior efficacy compared to standalone radiation therapy, further emphasizing the advantages of hyperthermia treatment.

Cost Challenges Despite its effectiveness, the high cost of hyperthermia treatment compared to other cancer procedures is a significant impediment to market growth. In the United States, the average charge for hyperthermia treatment for each cancer type is approximately US$ 50,000. Given that hyperthermia treatment often complements radiation or chemotherapy, the overall cost can be prohibitive for many patients.

Untapped Opportunities in Developing Economies Countries like China and India, with their large populations and high cancer incidence rates, present untapped opportunities for hyperthermia treatment. Although the number of facilities and experienced practitioners for cancer treatment in these countries is currently limited, the growing incidence of cancer is driving the expansion of healthcare infrastructure. This development creates a promising market for hyperthermia device manufacturers to introduce cost-effective and accessible products tailored to the needs of emerging economies.

Market Taxonomy

By Device Type

  • Microwave Hyperthermia Device
  • Ultrasound Hyperthermia Device
  • Infrared Hyperthermia Device
  • Short-wave Hyperthermia Device

By End User

  • Hospitals
  • Clinics
  • Research Institutes
  • Cancer Centers
  • Others

By Application

  • Breast Cancer
  • Liver Cancer
  • Soft Tissue Sarcoma
  • Leukemia
  • Head and Neck Tumors
  • Prostate Cancer
  • Others

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Hyperthermia Treatment for Cancer Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Production Output and Trade Statistics, 2018 - 2023

  • 3.1. Global Hyperthermia Treatment for Cancer Market Production Output, by Region, Value (US$ Mn) and Volume (Million Units), 2018 - 2023
    • 3.1.1. North America
    • 3.1.2. Europe
    • 3.1.3. Asia Pacific
    • 3.1.4. Latin America
    • 3.1.5. Middle East and Africa

4. Price Analysis, 2018 - 2023

  • 4.1. Global Average Price Analysis, by Device Type/ Application, US$ Per Unit, 2018 - 2023
  • 4.2. Prominent Factor Affecting Breast Tissue Markers Prices
  • 4.3. Global Average Price Analysis, by Region, US$ Per Unit

5. Global Hyperthermia Treatment for Cancer Market Outlook, 2018 - 2031

  • 5.1. Global Hyperthermia Treatment for Cancer Market Outlook, by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Microwave Hyperthermia Device
      • 5.1.1.2. Ultrasound Hyperthermia Device
      • 5.1.1.3. Infrared Hyperthermia Device
      • 5.1.1.4. Short-wave Hyperthermia Device
  • 5.2. Global Hyperthermia Treatment for Cancer Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Breast Cancer
      • 5.2.1.2. Liver Cancer
      • 5.2.1.3. Soft Tissue Sarcoma
      • 5.2.1.4. Leukemia
      • 5.2.1.5. Head and Neck Tumors
      • 5.2.1.6. Prostate Cancer
      • 5.2.1.7. Others
  • 5.3. Global Hyperthermia Treatment for Cancer Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospitals
      • 5.3.1.2. Clinics
      • 5.3.1.3. Research Institutes
      • 5.3.1.4. Cancer Centres
      • 5.3.1.5. Others
  • 5.4. Global Hyperthermia Treatment for Cancer Market Outlook, by Region, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. North America
      • 5.4.1.2. Europe
      • 5.4.1.3. Asia Pacific
      • 5.4.1.4. Latin America
      • 5.4.1.5. Middle East & Africa

6. North America Hyperthermia Treatment for Cancer Market Outlook, 2018 - 2031

  • 6.1. North America Hyperthermia Treatment for Cancer Market Outlook, by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Microwave Hyperthermia Device
      • 6.1.1.2. Ultrasound Hyperthermia Device
      • 6.1.1.3. Infrared Hyperthermia Device
      • 6.1.1.4. Short-wave Hyperthermia Device
  • 6.2. North America Hyperthermia Treatment for Cancer Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Breast Cancer
      • 6.2.1.2. Liver Cancer
      • 6.2.1.3. Soft Tissue Sarcoma
      • 6.2.1.4. Leukemia
      • 6.2.1.5. Head and Neck Tumors
      • 6.2.1.6. Prostate Cancer
      • 6.2.1.7. Others
  • 6.3. North America Hyperthermia Treatment for Cancer Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospitals
      • 6.3.1.2. Clinics
      • 6.3.1.3. Research Institutes
      • 6.3.1.4. Cancer Centres
      • 6.3.1.5. Others
  • 6.4. North America Hyperthermia Treatment for Cancer Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. U.S. Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.4.1.2. U.S. Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.4.1.3. U.S. Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.4.1.4. Canada Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.4.1.5. Canada Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.4.1.6. Canada Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Hyperthermia Treatment for Cancer Market Outlook, 2018 - 2031

  • 7.1. Europe Hyperthermia Treatment for Cancer Market Outlook, by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Microwave Hyperthermia Device
      • 7.1.1.2. Ultrasound Hyperthermia Device
      • 7.1.1.3. Infrared Hyperthermia Device
      • 7.1.1.4. Short-wave Hyperthermia Device
  • 7.2. Europe Hyperthermia Treatment for Cancer Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Breast Cancer
      • 7.2.1.2. Liver Cancer
      • 7.2.1.3. Soft Tissue Sarcoma
      • 7.2.1.4. Leukemia
      • 7.2.1.5. Head and Neck Tumors
      • 7.2.1.6. Prostate Cancer
      • 7.2.1.7. Others
  • 7.3. Europe Hyperthermia Treatment for Cancer Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospitals
      • 7.3.1.2. Clinics
      • 7.3.1.3. Research Institutes
      • 7.3.1.4. Cancer Centres
      • 7.3.1.5. Others
  • 7.4. Europe Hyperthermia Treatment for Cancer Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Germany Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.2. Germany Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.3. Germany Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.4. U.K. Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.5. U.K. Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.6. U.K. Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.7. France Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.8. France Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.9. France Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.10. Italy Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.11. Italy Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.12. Italy Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.13. Turkey Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.14. Turkey Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.15. Turkey Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.16. Russia Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.17. Russia Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.18. Russia Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.19. Rest of Europe Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.20. Rest of Europe Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.4.1.21. Rest of Europe Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Hyperthermia Treatment for Cancer Market Outlook, 2018 - 2031

  • 8.1. Asia Pacific Hyperthermia Treatment for Cancer Market Outlook, by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Microwave Hyperthermia Device
      • 8.1.1.2. Ultrasound Hyperthermia Device
      • 8.1.1.3. Infrared Hyperthermia Device
      • 8.1.1.4. Short-wave Hyperthermia Device
  • 8.2. Asia Pacific Hyperthermia Treatment for Cancer Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Breast Cancer
      • 8.2.1.2. Liver Cancer
      • 8.2.1.3. Soft Tissue Sarcoma
      • 8.2.1.4. Leukemia
      • 8.2.1.5. Head and Neck Tumors
      • 8.2.1.6. Prostate Cancer
      • 8.2.1.7. Others
  • 8.3. Asia Pacific Hyperthermia Treatment for Cancer Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospitals
      • 8.3.1.2. Clinics
      • 8.3.1.3. Research Institutes
      • 8.3.1.4. Cancer Centres
      • 8.3.1.5. Others
  • 8.4. Asia Pacific Hyperthermia Treatment for Cancer Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. China Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.4.1.2. China Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.4.1.3. China Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.4.1.4. Japan Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.4.1.5. Japan Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.4.1.6. Japan Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.4.1.7. South Korea Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.4.1.8. South Korea Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.4.1.9. South Korea Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.4.1.10. India Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.4.1.11. India Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.4.1.12. India Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.4.1.13. Southeast Asia Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.4.1.14. Southeast Asia Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.4.1.15. Southeast Asia Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.4.1.16. Rest of Asia Pacific Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.4.1.17. Rest of Asia Pacific Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.4.1.18. Rest of Asia Pacific Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Hyperthermia Treatment for Cancer Market Outlook, 2018 - 2031

  • 9.1. Latin America Hyperthermia Treatment for Cancer Market Outlook, by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 9.1.1. Key Highlights
      • 9.1.1.1. Microwave Hyperthermia Device
      • 9.1.1.2. Ultrasound Hyperthermia Device
      • 9.1.1.3. Infrared Hyperthermia Device
      • 9.1.1.4. Short-wave Hyperthermia Device
  • 9.2. Latin America Hyperthermia Treatment for Cancer Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 9.2.1.1. Breast Cancer
      • 9.2.1.2. Liver Cancer
      • 9.2.1.3. Soft Tissue Sarcoma
      • 9.2.1.4. Leukemia
      • 9.2.1.5. Head and Neck Tumors
      • 9.2.1.6. Prostate Cancer
      • 9.2.1.7. Others
  • 9.3. Latin America Hyperthermia Treatment for Cancer Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 9.3.1. Key Highlights
      • 9.3.1.1. Hospitals
      • 9.3.1.2. Clinics
      • 9.3.1.3. Research Institutes
      • 9.3.1.4. Cancer Centres
      • 9.3.1.5. Others
  • 9.4. Latin America Hyperthermia Treatment for Cancer Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 9.4.1. Key Highlights
      • 9.4.1.1. Brazil Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 9.4.1.2. Brazil Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 9.4.1.3. Brazil Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 9.4.1.4. Mexico Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 9.4.1.5. Mexico Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 9.4.1.6. Mexico Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 9.4.1.7. Argentina Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 9.4.1.8. Argentina Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 9.4.1.9. Argentina Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 9.4.1.10. Rest of Latin America Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 9.4.1.11. Rest of Latin America Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 9.4.1.12. Rest of Latin America Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Hyperthermia Treatment for Cancer Market Outlook, 2018 - 2031

  • 10.1. Middle East & Africa Hyperthermia Treatment for Cancer Market Outlook, by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 10.1.1. Key Highlights
      • 10.1.1.1. Microwave Hyperthermia Device
      • 10.1.1.2. Ultrasound Hyperthermia Device
      • 10.1.1.3. Infrared Hyperthermia Device
      • 10.1.1.4. Short-wave Hyperthermia Device
  • 10.2. Middle East & Africa Hyperthermia Treatment for Cancer Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 10.2.1. Key Highlights
      • 10.2.1.1. Breast Cancer
      • 10.2.1.2. Liver Cancer
      • 10.2.1.3. Soft Tissue Sarcoma
      • 10.2.1.4. Leukemia
      • 10.2.1.5. Head and Neck Tumors
      • 10.2.1.6. Prostate Cancer
      • 10.2.1.7. Others
  • 10.3. Middle East & Africa Hyperthermia Treatment for Cancer Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 10.3.1. Key Highlights
      • 10.3.1.1. Hospitals
      • 10.3.1.2. Clinics
      • 10.3.1.3. Research Institutes
      • 10.3.1.4. Cancer Centres
      • 10.3.1.5. Others
  • 10.4. Middle East & Africa Hyperthermia Treatment for Cancer Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 10.4.1. Key Highlights
      • 10.4.1.1. GCC Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 10.4.1.2. GCC Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 10.4.1.3. GCC Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 10.4.1.4. South Africa Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 10.4.1.5. South Africa Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 10.4.1.6. South Africa Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 10.4.1.7. Egypt Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 10.4.1.8. Egypt Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 10.4.1.9. Egypt Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 10.4.1.10. Nigeria Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 10.4.1.11. Nigeria Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 10.4.1.12. Nigeria Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 10.4.1.13. Rest of Middle East & Africa Hyperthermia Treatment for Cancer Market by Device Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 10.4.1.14. Rest of Middle East & Africa Hyperthermia Treatment for Cancer Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 10.4.1.15. Rest of Middle East & Africa Hyperthermia Treatment for Cancer Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 10.4.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

  • 11.1. Artery Type vs Indication Heatmap
  • 11.2. Manufacturer vs Indication Heatmap
  • 11.3. Company Market Share Analysis, 2023
  • 11.4. Competitive Dashboard
  • 11.5. Company Profiles
    • 11.5.1. Celsius42 GmbH
      • 11.5.1.1. Company Overview
      • 11.5.1.2. Product Portfolio
      • 11.5.1.3. Financial Overview
      • 11.5.1.4. Business Strategies and Development
    • 11.5.2. Pyrexar Medical Inc.
      • 11.5.2.1. Company Overview
      • 11.5.2.2. Product Portfolio
      • 11.5.2.3. Financial Overview
      • 11.5.2.4. Business Strategies and Development
    • 11.5.3. Oncothermia
      • 11.5.3.1. Company Overview
      • 11.5.3.2. Product Portfolio
      • 11.5.3.3. Financial Overview
      • 11.5.3.4. Business Strategies and Development
    • 11.5.4. Hydrosun GmbH
      • 11.5.4.1. Company Overview
      • 11.5.4.2. Product Portfolio
      • 11.5.4.3. Financial Overview
      • 11.5.4.4. Business Strategies and Development
    • 11.5.5. Yamamoto Vinita Co., Ltd
      • 11.5.5.1. Company Overview
      • 11.5.5.2. Product Portfolio
      • 11.5.5.3. Financial Overview
      • 11.5.5.4. Business Strategies and Development
    • 11.5.6. Andromedic Srl
      • 11.5.6.1. Company Overview
      • 11.5.6.2. Product Portfolio
      • 11.5.6.3. Financial Overview
      • 11.5.6.4. Business Strategies and Development
    • 11.5.7. Haifu Medical Technology Co. Ltd
      • 11.5.7.1. Company Overview
      • 11.5.7.2. Product Portfolio
      • 11.5.7.3. Financial Overview
      • 11.5.7.4. Business Strategies and Development

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Report Assumptions
  • 12.3. Acronyms and Abbreviations